Neonatal Research Priority Setting Partnership: help wanted

Katie Evans
Neonatal Research Priority Setting Partnership Project Co-ordinator and Clinical Research Fellow in Neonatal Medicine at Chelsea and Westminster Hospital
katie.evans7@nhs.net

Chris Gale
Academic Neonatologist and Neonatal Society Meeting Secretary

Full text available by subscription ...

The full text of this article is available to subscribers in text, and in Tablet/iPad format and as a PDF file.

Please subscribe and log in to see the full article.

Keywords

Nocardia; pneumonia; immune deficiency; thrombocytopenia; chronic granulomatous disease

Key points

N. farcinicais an infrequent but clinically aggressive infection usually associated with immunocompromised patients.
Extreme prematurity may be a contributing factor for acquiring nocardial infection.

Also published in Infant:

VOLUME 9/ISSUE 2, MARCH 2013

Severe combined immunodeficiency in the newborn

Severe combined immunodeficiencies (SCIDs) are a group of rare diseases of T-lymphocyte or thymic failure, which comprise the most severe immunodeficiencies. Generally fatal by one year of age without treatment, they constitute a paediatric emergency and early diagnosis facilitates a better prognosis. This article will review the molecular mechanisms of SCID, clinical signs and symptoms, diagnostic investigations and review treatment modalities and outcomes, and discuss future developments.